Loading
Africa's new continental medicines agency could assess cancer drugs once for 55 countries. It needs oncology reviewers and a reliance rule to do it.
The African Medicines Agency is becoming operational, building on AVAREF and regional harmonisation initiatives (EAC, SADC). Oncology medicines are a small share of African registrations and most national agencies lack oncology reviewers. The proposal is a philanthropically funded oncology unit within AMA running continental joint assessments, relying on WHO-listed authority reports, with member states committing to national decisions within 60 days of an AMA recommendation. The WHO/St Jude childhood cancer medicines platform provides demand.
Shares Regulatory divergence between regions, Most of the world has almost no cancer care.
Shares Regulatory divergence between regions, Most of the world has almost no cancer care.
Shares Regulatory divergence between regions, Most of the world has almost no cancer care.
Shares Regulatory divergence between regions, Most of the world has almost no cancer care.
Shares Regulatory divergence between regions, Most of the world has almost no cancer care.
Shares Regulatory divergence between regions, Most of the world has almost no cancer care.
Shares Regulatory divergence between regions, Most of the world has almost no cancer care.
Shares Regulatory divergence between regions, Most of the world has almost no cancer care.